Core Laboratories is expected to report Q4 earnings on Jan. 30. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Core Laboratories's revenues will grow 1.0% and EPS will grow 3.7%.
The average estimate for revenue is $246.3 million. On the bottom line, the average EPS estimate is $1.13.
Last quarter, Core Laboratories reported revenue of $245.4 million. GAAP reported sales were 6.1% higher than the prior-year quarter's $231.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.13. GAAP EPS of $1.14 for Q3 were 23% higher than the prior-year quarter's $0.93 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 36.7%, 170 basis points better than the prior-year quarter. Operating margin was 30.0%, 200 basis points better than the prior-year quarter. Net margin was 22.2%, 280 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $973.0 million. The average EPS estimate is $4.48.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 576 members out of 587 rating the stock outperform, and 11 members rating it underperform. Among 145 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 144 give Core Laboratories a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Core Laboratories is hold, with an average price target of $127.71.
Is Core Laboratories the right energy stock for you? Read about a handful of timely, profit-producing plays on expensive crude in "3 Stocks for $100 Oil." Click here for instant access to this free report.
- Add Core Laboratories to My Watchlist.
This article was originally published as What Does Wall Street See for Core Laboratories's Q4?on Fool.com
Copyright © 2009 The Motley Fool, LLC. All rights reserved.
Wounded vets say Segways help them see the world at eye level.
What famous actor should be cast to play this guy?
J.K. Rowling scribbled notes and drawings in a first-edition copy.
Scenes from last night's show and spectacle in Las Vegas.(Photos)